Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
This review focuses on the use of oxadiazoles as translational readthrough-inducing drugs (TRIDs) to rescue the functional full-length protein expression in mendelian genetic diseases caused by nonsense mutations. These mutations in specific genes generate premature termination codons (PTCs) respons...
Main Authors: | Ambra Campofelice, Laura Lentini, Aldo Di Leonardo, Raffaella Melfi, Marco Tutone, Andrea Pace, Ivana Pibiri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/13/3329 |
Similar Items
-
Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model Systems
by: Ivana Pibiri, et al.
Published: (2020-09-01) -
Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches
by: Silvia Lombardi, et al.
Published: (2020-12-01) -
Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations
by: Daniel R. McHugh, et al.
Published: (2021-12-01) -
Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner
by: Sylwia Michorowska
Published: (2021-08-01) -
Functional recovery of a novel knockin mouse model of dysferlinopathy by readthrough of nonsense mutation
by: Kyowon Seo, et al.
Published: (2021-06-01)